AU Stock MarketDetailed Quotes

Neurizon Therapeutics Ltd (NUZOA)

Watchlist
  • 0.002
  • 0.0000.00%
20min DelayMarket Closed Apr 24 10:00 AET
0Market Cap0.00P/E (Static)

Neurizon Therapeutics Ltd (NUZOA) Revenue Breakdown Overview

By Business/Source

Currency:AUD
2023/FY
Stock NameRevenueRatio
Pharmaceutical - Epichem3.11M110.25%
Corporate950.39K33.66%
Inter-segment Elimination-163.51K-5.79%
Other income-1.08M-38.12%

By Country/Region

Currency:AUD
2023/FY
Stock NameRevenueRatio
Australia2.69M95.17%
United States of America100.44K3.56%
Other18.76K0.66%
Switzerland17.28K0.61%
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More